JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
AMRX Financials - Amneal Pharmaceuticals Income & Cash Flow | Ledgeburg
AMRX - Amneal Pharmaceuticals, Inc.
USD | NASDAQ | Healthcare
Summary
Summary AMRX Stock
Financials
Financials AMRX Stock
Loading...
Loading...
Income Statement
Income Statement AMRX Stock
Balance Sheet
Balance Sheet AMRX Stock
Cash Flow Statement
Cash Flow Statement AMRX Stock
Loading...
Loading...
Home
Stocks
Amneal Pharmaceuticals, Inc. (AMRX)
Financials
Financials of AMRX
Loading...
Loading...
Loading...
Loading...
Revenue
$3.01876B
Operating Income
$394.096M
Net Income
$127.933M
Share Count (Basic)
313.367M
Operating Cash Flow
$339.992M
Free Cash Flow
$269.929M
Cash And Short-Term Equivalents
$282.029M
Total Debt
$2.571876B
Annual
Quarterly
Revenue $USD
0
1B
2B
3B
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
200M
400M
600M
800M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-300M
-200M
-100M
0
100M
Annual
Quarterly
Margins
Gross
Operating
Net
-10%
0%
10%
20%
30%
40%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
0
20M
40M
60M
80M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
0%
10%
20%
30%
40%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26